708
Participants
Start Date
August 31, 2001
Primary Completion Date
November 30, 2005
Study Completion Date
November 30, 2005
Rivastigmine
New York
Greensburg
Allentown
Charleston
Miami Beach
Boynton Beach
Indianapolis
Des Moines
Houston
Austin
Irvine
San Francisco
Portland
Port Charlotte
St Louis
Albuquerque
Graz
Linz
Vienna
Edmonton
Ottawa
Toronto
Montreal
Amiens
Bordeaux
Lille
Marseille
Montpellier
Toulouse
Tours
Bautzen
Berlin
Bochum
Chemnitz
Eisenhüttenstadt
Erlangen
Freiburg im Breisgau
Lüdenscheid
Osnabrück
Ancona
Brescia
Florence
Perugia
Reggio Emilia
Roma
Vicenza
Moscow
Saint Petersburg
Barakaldo
Barcelona
Madrid
Pamplona
Saint Cugat Del Valles
Basel
Lausanne
Newcastle upon Tyne
Swindon
Bristol
Clydebank
East Sussex
Lytham St Annes
Southampton
Bennington
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY